Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study (Q34389992)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study |
scientific article |
Statements
1 reference
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study (English)
1 reference
Vassili Valayannopoulos
1 reference
Eugen Mengel
1 reference
Roberto Giugliani
1 reference
Christian J Hendriksz
1 reference
Barbara Burton
1 reference
Thomas R Fleming
1 reference
Paul Harmatz
1 reference
Derralynn Hughes
1 reference
Simon A Jones
1 reference
Shuan-Pei Lin
1 reference
Maurizio Scarpa
1 reference
STRIVE Investigators
1 reference
Peter Slasor
1 reference
Debra Lounsbury
1 reference
Wolfgang Dummer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference